
Europe - Frankfurt Stock Exchange - FRA:NZM2 - DK0060336014 - Common Stock
The current stock price of NZM2.DE is 54.68 EUR. In the past month the price increased by 2.78%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AKU1.DE | AKZO NOBEL N.V. | 16.15 | 10.06B | ||
| AKZA.AS | AKZO NOBEL N.V. | 16.33 | 10.17B | ||
| SY1.DE | SYMRISE AG | 19.3 | 9.79B | ||
| SYENS.BR | SYENSQO SA | 21.85 | 7.38B | ||
| 1EVK.MI | EVONIK INDUSTRIES AG | 7.95 | 6.18B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 9.76 | 6.19B | ||
| UMI.BR | UMICORE | 17.27 | 4.81B | ||
| NVJP.DE | UMICORE | 17.01 | 4.74B | ||
| AKE.PA | ARKEMA | 10.36 | 4.06B | ||
| WCH.DE | WACKER CHEMIE AG | 163.37 | 3.66B | ||
| RBT.PA | ROBERTET SA | 18.76 | 1.91B | ||
| ACT.DE | ALZCHEM GROUP AG | 27.51 | 1.71B |
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
NOVONESIS (NOVOZYMES) B
Krogshoejvej 36
Bagsvaerd DK
Employees: 10582
Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
The current stock price of NZM2.DE is 54.68 EUR. The price increased by 0.26% in the last trading session.
NOVONESIS (NOVOZYMES) B (NZM2.DE) has a dividend yield of 1.58%. The yearly dividend amount is currently 0.67.
NZM2.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NZM2.DE.
NOVONESIS (NOVOZYMES) B (NZM2.DE) will report earnings on 2026-02-25, after the market close.
ChartMill assigns a technical rating of 5 / 10 to NZM2.DE.
ChartMill assigns a fundamental rating of 5 / 10 to NZM2.DE. NZM2.DE has an excellent profitability rating, but there are some minor concerns on its financial health.
Over the last trailing twelve months NZM2.DE reported a non-GAAP Earnings per Share(EPS) of 1.51. The EPS decreased by -54.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.61% | ||
| ROA | 4.31% | ||
| ROE | 6.54% | ||
| Debt/Equity | 0.26 |
23 analysts have analysed NZM2.DE and the average price target is 64.71 EUR. This implies a price increase of 18.34% is expected in the next year compared to the current price of 54.68.
For the next year, analysts expect an EPS growth of 44.83% and a revenue growth 6.01% for NZM2.DE